YA-CHEN TINA SHIH to Imatinib Mesylate
This is a "connection" page, showing publications YA-CHEN TINA SHIH has written about Imatinib Mesylate.
Connection Strength
0.496
-
Treatment value of second-generation BCR-ABL1 tyrosine kinase inhibitors compared with imatinib to achieve treatment-free remission in patients with chronic myeloid leukaemia: a modelling study. Lancet Haematol. 2019 Aug; 6(8):e398-e408.
Score: 0.483
-
Idiopathic hypereosinophilic syndrome with infiltration of cerebrospinal fluid by immature eosinophils: a case report and literature review. Surg Neurol. 2007; 68 Suppl 1:S52-5; discussion S55.
Score: 0.013